We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dexion Alp. | LSE:DASL | London | Ordinary Share | GB00B0ZQ8Q41 | ORD NPV GBP |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 85.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDASL RNS Number : 9330U Dexion Alpha Strategies Limited 01 July 2009 Dexion Alpha Strategies Limited (the "Company") Estimated Net Asset Values Ordinary Shares As at the close of business on 26th June 2009, the estimated net asset values of the Company's ordinary shares are as follows:- +------------+--------------+-------------+--------------+--------------+ | Share | NAV | Since | MTD | YTD | | Class | | 19th June |Performance* | Performance | | | |Performance | | | +------------+--------------+-------------+--------------+--------------+ |GBP Shares | 95.97 pence | -0.29% | -0.09% | +5.29% | +------------+--------------+-------------+--------------+--------------+ |EUR Shares | EUR 1.1588 | -0.31% | -0.05% | +2.71% | +------------+--------------+-------------+--------------+--------------+ |US$ Shares | US$ 1.6330 | -0.29% | -0.06% | +3.26% | +------------+--------------+-------------+--------------+--------------+ * Based on Final NAV for 29th May 2009 reported on 30th June 2009. These valuations, which have been prepared in good faith by the Company's administrator, are for information purposes only and are based on the unaudited estimated valuations supplied to the Company's investment adviser by the administrators or managers of the Company's underlying investments and such valuations may not be considered independent or may be subject to potential conflicts of interest. Both weekly manager estimates and monthly valuations may be produced as at valuation dates which do not co-incide with valuation dates for the Company, may be based on valuations provided as of a significantly earlier date, may differ materially from the actual value of the Company's portfolio and are unaudited or may be subject to little verification or other due diligence and may not comply with generally accepted accounting practices or other generally accepted valuation principles. The Company's investment adviser, investment manager and administrator may not have sufficient information to confirm or review the completeness or accuracy of information provided by those managers or administrators of the Company's investments. In addition, those entities may not provide estimates of the value of the underlying funds in which the Company invests on a regular or timely basis or at all with the result that the values of such investments may be estimated by the investment manager. In the case of 5 of the Company's 51 investments, where no such formal valuation has been received by today's date, an estimated valuation prepared by the Company's investment adviser or by the manager or administrator of the underlying funds has been used. Certain other risk factors which may be relevant to these valuations are set out in the Company's prospectus dated 10 March 2006. This information is provided by RNS The company news service from the London Stock Exchange END NAVILFISDEILIIA
1 Year Dexion Alpha Strategies Chart |
1 Month Dexion Alpha Strategies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions